Interestingly, IL-22 production and IL-22/AhR mRNA was significantly elevated in lung-resident CD4+ T cells from tumor site in comparison with those from nontumor site (all P<0.0001, Figure 3D,E,G). The gene discussed is IL22; the disease is neoplasm.